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a b s t r a c t
Ectopic expression of Simian Virus 40 (SV40) large T antigen (LT) in mouse embryonic ﬁbroblasts (MEFs)
increased levels of mRNAs encoding interferon stimulated genes (ISGs). The mechanism by which T
antigen increases levels of ISGs in MEFs remains unclear. We present evidence that expression of T
antigen from SV40, Human Polyomaviruses BK (BKV) or JC (JCV) upregulate production of ISGs in MEFs,
and subsequently result in an antiviral state, as determined by inhibition of VSV or EMCV growth. The
ﬁrst 136 amino acids of LT are sufﬁcient for these activities. Furthermore, increased ISG expression and
induction of the antiviral state requires STAT1. Finally, the RB binding motif of LT is necessary for
activation of STAT1. We conclude that the induction of the STAT1 mediated innate immune response in
MEFs is a common feature shared by SV40, BKV and JCV.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Members of Polyomaviridae are circular dsDNA viruses near
5 kb in length, and sometimes establish persistent infections
within a permissive host. Some viruses from the family have been
linked with diseases in humans. The human polyomaviruses BKV
and JCV are reported to be present in up to 80% of adults, and can
incite serious disease in immunocompromised patients (Pinto and
Dobson, 2014). Speciﬁcally, BKV has been implicated as an etiolo-
gic protagonist of hemorrhagic cystitis in bone marrow transplant
patients (Arthur et al., 1986), and JCV infection has been linked to
the incidence of progressive multifocal leukoencephalopathy in
immunosuppressed patients (Padgett et al., 1976). While the SV40
has not been clearly linked to human disease, it bears similarity to
the human polyomaviruses (BKV and JCV) and is well known for
its contribution to the study of tumorigenesis in mammalian
models (Black and Rowe, 1964).
SV40, BKV, and JCV share a relatively high degree of genome
sequence homology (approximately 70%) and T antigen transcripts
are produced from their early regions (Pinto and Dobson, 2014;
McNees et al., 2005). The viral early regions express multiple
T antigen mRNAs as a result of differential splicing. All three viruses
encode a large T antigen (LT) and a small t antigen (sT) (Fig. 1A).
Additional T antigen products include: a 17kT antigen (17kT) from
SV40, a truncated T antigen (truncT) from BKV, and three T prime (T0)
T antigens (T0135, T0136, T0165) from JCV (Trowbridge and Frisque,
1995; Gjoerup and Chang, 2010; Abend et al., 2009). The T antigens
are the ﬁrst proteins expressed from the viral genome, and LT initiates
viral DNA replication and transcription. LT is needed to drive the host
cell into S phase so as to aid in ampliﬁcation of the viral genome and
facilitate progeny assembly (Pipas, 2009; Damania and Pipas, 2009).
The LT from SV40, BKV, and JCV are known to induce oncogenic
transformation via the disruption of cellular tumor suppressor p53
and retinoblastoma protein (pRB) family members: pRB, p107, and
p130 (An et al., 2012). LT abrogates the activity of p53 by binding
to it through its ATPase domain (Bargonetti et al., 1991) and
blocking the p53 DNA binding domain (Bargonetti et al., 1992).
LT also binds the pRBs via its LXCXE motif (Dyson et al., 1990,
DeCaprio et al., 1988), and releases cellular E2F transcription
factors; thus driving the cell into S phase (Sullivan et al., 2001).
The LTs from SV40, JCV, and BKV are very similar in domain
structure (Fig. 1B).
Previous studies have shown that SV40 LT (Forero et al., 2014;
Rathi et al., 2010) or JCV genomic DNA (Verma et al., 2006) alter
the expression of interferon stimulated genes (ISGs) in mouse and
human cells. Moreover, expression of SV40 LT in primary mouse
embryonic ﬁbroblasts (MEFs) results in the upregulation of many
ISGs (Rathi et al., 2010). Interestingly, this phenotype is indepen-
dent of viral infection, and was activated in the absence of
interferon (IFN) production (Rathi et al., 2010). During normal
viral infection, a virus is recognized by pathogen recognition
receptors (PRRs), which bind to the pathogen-associated molecu-
lar patterns (PAMPs) speciﬁc for the virus. This binding induces a
signaling cascade leading to the production of IFN. Secreted IFN
will then bind to the IFN receptor expressed on the cell surface,
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and stimulate type I or II IFN-mediated signaling pathways. The
STAT transcription factors (Signal Transducers and Activator of
Transcription) are phosphorylated and thus activated as a result of
IFN pathway stimulation. At this point, STAT molecules dimerize
and translocate to the nucleus, where they bind to gene promoters
and activate the transcription of ISGs (Platanias, 2005; Kawai and
Akira, 2006). Interferon stimulated genes are known to have
various roles, but are often associated with antiviral activities
(Samuel, 1991; Darnell et al., 1994; Schoggins et al., 2011).
We have investigated the role of T antigen in the upregulation
of ISGs observed in MEFs. Activity within the J domain and the
downstream linker of LT from SV40, BKV, and JCV is sufﬁcient to
increase transcription of ISGs. The induction of ISGs by T antigen
results in an antiviral state, as seen by the attenuation of virus
growth. The upregulation of ISGs and the antiviral state depends
on STAT1 transcription factor, with activation of STAT1 dependent
upon T antigen activity via the pRB binding motif.
Results
Polyomavirus T antigens upregulate ISGs
To determine if T antigens produced from viral early regions
(ER) upregulate ISGs, whole cell extracts and total RNAs were
examined from MEF pools stably expressing SV40, BKV, or JCV ERs.
Fig. 1A shows the possible transcripts expressed by the ER. Our
analysis conﬁrmed previous results that SV40 T antigen expression
upregulated STAT1 and ISGs when compared to wild-type MEFs
(Rathi et al., 2010; Forero et al., 2014). Additionally, we show by
western blot that total STAT1, activated STAT1, and also total STAT2
protein levels are increased in the presence of SV40, BKV, and JCV
ERs (Fig. 2A). The ISGs also exhibited elevated transcription levels
in the pools expressing any of the viral ER, as detected by reverse
transcription PCR (RT-PCR) (Fig. 2B).
The T antigen proteins produced by each genomic early region
are shown in Fig. 2C. Although each ER is capable of inducing the
transcription of ISGs, Fig. 2C reveals that the different ERs
produced various T antigen products, and not all possible products
were detected. SV40-ER produced both LT and sT, as shown by
western blot using antibodies capable of detecting all known T
antigens produced by SV40 (Harlow et al., 1981; Fu et al., 1996;
Bollag et al., 2000; Munoz-Marmol et al., 2004). However, we were
unable to detect the production of LT from BKV-ER. Instead,
BKV-ER preferentially produced either the sT, or truncT antigen
based on the apparent size of the detected T antigen (Seneca et al.,
2014). Examination of pools expressing JCV-ER showed production
of both LT and other alternative splice products which may include
sT, or the T's. These results demonstrate that the products from
ERs of SV40, JCV, and BKV are capable of activating the cellular
interferon response and upregulating production of ISGs. Addi-
tionally, the data suggests that ISG upregulation may not be solely
dependent on the LT as previously shown (Rathi et al., 2010; Forero
et al., 2014).
Small t antigen is not necessary to induce upregulation of ISGs
To evaluate the contribution of sT activity to the upregulation of
ISGs in MEFs, we generated MEF pools expressing LT cDNA from
SV40, BKV, and JCV, which were unable to produce sT (Fig. 3).
Under these conditions, MEFs expressed the corresponding LTs
from SV40, BKV, and JCV, as well as other non-sT T antigen
products (Fig. 3A). BKV LT cDNA also produced truncated T antigen,
and JCV LT cDNA produced at least two T's. Transcription of ISGs
was upregulated in the LT cDNA pools relative to wild-type MEFs,
and ISG levels were similar to those observed in MEFs expressing
the SV40-ER (Fig. 3B). We conclude that the upregulation of ISGs
in MEFs by SV40, BKV, and JCV does not depend on the presence
of sT.
The J-domain and downstream linker region of large T antigen
is sufﬁcient for upregulation of ISGs
To map the activity of LT necessary for ISG upregulation,
truncation mutants of the LT were examined. MEF pools expres-
sing truncation mutants of LT, either the ﬁrst 136 amino acids of
SV40 (SV40-N136), or the equivalents in BKV (BKV-N138) or JCV
(JCV-N137) were produced. The amino region truncations contain
a J domain, LXCXE motif, and nuclear localization signal (Fig. 4A).
The expression of the truncation mutant proteins in the MEF pools
is shown by western blot (Fig. 4B). The pools expressing the
truncation mutants retain the ability to produce sT via alternative
splicing; however no sT was detected by the western blot shown
in Fig. 4B.
Examination of cell pools expressing the amino terminal region
truncations revealed increased levels of interferon response
Fig. 1. Polyomavirus early region products. (A) Circular genomes for each virus are labeled with the T antigen products of the early region. Arrows indicate coding sequence,
and lines indicate introns. (B) Domain map of SV40 large T antigen. Notable features of large T antigen such as the J domain (J), pRB binding motif (LXCXE), nuclear
localization signal (NLS), origin binding domain (OBD), zinc ﬁnger (Zn), ATPase domain (ATPase), and host range region (HR) are indicated in the diagram.
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mediators, STATs (Fig. 4C), and downstream products, ISGs (Fig. 4D),
when compared to wild-type MEFs. However, BKV-N138 expressing
pools did not upregulate total STAT2 production (Fig. 4C, lane 3). This
was in contrast to cells expressing the BKV-ER. The total STAT2 levels
were increased in MEF pools expressing SV40-N136 or JCV-N137. We
conclude that activity by N136 equivalent truncation mutants is
sufﬁcient for the upregulation of the ISGs in MEFs.
A functional retinoblastoma protein binding motif in T antigen
is necessary to activate STAT1
To further narrow down the activity of the LT necessary to
induce the interferon response leading to the upregulation of ISGs,
we examined additional mutants within the full length LT of SV40,
and the SV40-N136. We produced two full length SV40 LT
expressing MEF clones, and a pool of MEFs expressing SV40-
N136 containing a mutated LXCXE motif. Protein expression of the
mutant T antigens is shown in Fig. 5B. The new mutant exhibits
two point mutations at E107K/E108K (E107/8K). The E107/8K
mutant is unable to bind pRB family members (DeCaprio et al.,
1988). In all MEFs expressing E107/8K mutants, the steady-state
levels of activated STAT1 S727 were not upregulated relative to
MEFs expressing normal LT or SV40-N136 (Fig. 5A). The phosphor-
ylation of STAT1 S727 results in translocation of STAT1 to the
nucleus and promotion of ISG transcription (Wen et al., 1995; Levy
and Darnell, 2002). These results indicate activation of STAT1 S727
in T antigen expressing MEFs is abrogated with a mutated LXCXE
motif. This suggests that the LXCXE motif is critical for activation of
STAT1, and may be necessary for ISG production.
The carboxy terminal region of large T antigen is defective
for the upregulation of ISGs
We next examined carboxy-terminal truncation mutants of the
LT from SV40 to determine if additional activities downstream of
the LXCXE motif were needed to upregulate the ISGs in MEFs. Two
pools of MEFs expressing a truncation mutant of the LT containing
amino acids 257–708 (C257, Fig. 5C) were generated. Fig. 5D shows
the protein expression of the C257 mutant via western blot.
Additional analyses were performed to assess the protein levels
Fig. 2. Polyomavirus early region upregulates ISGs. (A) Western blots were performed with 30 μg of whole cell extract from wild-type MEF and MEF pools expressing the
early region of SV40, BKV, and JCV. Total STAT1 and STAT2 and activated STAT1 (Ser 727) levels were detected with the appropriate antibodies. GAPDH served as the loading
control (B) The products of RT-PCR for various ISGs using cDNA made from 2 μg of total RNA from wild-type MEFs and the viral early regions expressing MEF pools were
resolved on a 1% agarose gel and visualized by ethidium bromide. (C) Steady state protein level of the T antigens produced by the viral early regions was determined by
western blot using 30 μg of whole cell extract from MEF expressing the various early regions. The data shown is representative of all pools tested.
Fig. 3. Large T antigen cDNA upregulates ISGs. (A) Western blots were performed with 30 μg of whole cell extract for expression of the T antigen proteins produced from
Large T cDNA MEF pools. T Antigens were detected with appropriate antibodies. (B) The products of RT-PCR for various ISGs using cDNA produced from 2 μg of total RNA from
wild-type MEFs, or the Large T cDNA MEF pools are shown. Lane 2 shows ISG transcription levels of the SV40-ER MEF pool for comparison. The data shown is an average of all
pools tested.
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of STATs and ISG transcription levels (Fig. 5D and E). Both MEF
pools expressing C257 were defective for the upregulation of total
and activated STAT1 relative to SVT-ER T antigen expression
(Fig. 5D, lanes 3 and 4), as well as the ISGs (Fig. 5E). Moreover,
total STAT2 levels varied between the two pools examined, i.e.,
STAT2 was upregulated in the second MEF pool tested not the ﬁrst.
These results indicate that the carboxy-terminal region of LT is
defective for the upregulation of ISGs.
Polyomavirus T antigen activates an antiviral state
As the interferon response is upregulated following viral
infection, and results in a defensive (antiviral) state by the cell
against the pathogen (Samuel, 1991), we hypothesized that the
increase in ISGs by T antigen would establish an antiviral state. To
test this, we challenged the MEF pools expressing T antigen with
vesicular stomatitis virus (VSV), a positive sense RNA virus, and
performed plaque assays to quantify viral growth. RNA viruses
have been shown to be attenuated by the production of ISGs (e.g.
OAS2) (Silverman, 2007; Lin et al., 2009; Fensterl et al., 2012), and
thus served as a good candidate for assessment of antiviral state.
VSV was grown on either wild-type MEFs or MEFs expressing
the SV40, BKV, or JCV ERs. Supernatants containing viruses were
harvested from MEF pools at various time points, and subjected to
plaque assay to generate virus growth curves. Fig. 6A shows the
average of VSV production by four different lineages of wild-type
MEFs over a period of 48 h post-infection. Fig. 6B shows the
average production of VSV growth from multiple infections of ER-
expressing MEF pools normalized against the wild-type levels.
That is, the VSV production from ER expressing MEFs relative to
VSV production from wild-type MEFs displayed as a proportion.
Infections were performed with at least two different lineages
MEFs. These results reveal clearly that VSV growth is inhibited by
the presence of T antigen produced from the ERs. ER expressing
MEFs show less than ten percent of the VSV production observed
in wild-type from 12 h post-infection and later time points. Similar
results were obtained from MEFs expressing the N136 equivalents
Fig. 6C. Speciﬁcally, greater than 90% of VSV production was
blocked in SV40-N136 and JCV-N137 from 12 to 48 h post-
infection. BKV-N138 reduced VSV growth to similar levels as
SV40-N136 and JCV-N137 except at 48 h where viral growth was
inhibited 2 fold. Together, these data suggest that the rate of VSV
growth is substantially attenuated in the presence of T antigen.
In order to determine if the antiviral state established by
T antigen was speciﬁc to VSV, we prepared additional virus growth
curves with encephalomyocarditis virus (EMCV). Wild type, SV40-
ER MEFs, and N136 MEFs, were challenged with EMCV. The
cellular supernatant was harvested at various time points, and
viral replication was quantiﬁed by plaque assay. Fig. 6D shows the
production of EMCV growth (pfu/mL) in SV40-ER, SV40-N136, or
wild-type MEFs. We observed that EMCV growth was attenuated
by at least three to four logs10 in the T antigen expressing MEFs
compared to wild-type at three hours post-infection. Based on the
evidence from both VSV and EMCV viral growth curves, we
conclude that expression of T antigen in MEFs activates an
antiviral state.
STAT1 transcription factor is necessary to establish the T antigen
induced antiviral state
Given that the STAT1 transcription factor is a critical mediator
of IFN signaling pathways and for the establishment of the
Fig. 4. J-domain and downstream linker region of large T antigen upregulate ISGs. (A) A diagram of the ﬁrst 136 amino acids of SV40 Large T antigen (N136). The features
shown (as indicated in Fig. 1) are also shared with the equivalent amino truncation mutant of BKV (N138) and JCV (N137). (B) Western blot was performed with 30 μg of
whole cell extract to show the production of N136 equivalent truncation mutants in MEF pools. (C) Western blot showing the production of STAT1 and STAT2 in whole cell
extract from wild-type MEFs (lane 1) or MEF pools expressing N136 equivalents (lanes 2–4). D) RT-PCRs for various ISGs using cDNA made from 2 μg of total RNA fromwild-
type MEFs (lane 2), or the N136 equivalent mutant MEF pools (lane 3–5). The SV40-ER MEF pool is included for comparison (lane 1). The data shown is an average of all pools
tested.
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antiviral state (Horvath and Darnell, 1996), we hypothesized that T
antigen may be inducing ISG production via STAT1 signaling. To
determine if the upregulation of ISGs by T antigen requires STAT1,
pools of STAT1(/) MEFs expressing T antigen were examined.
Fig. 7A and B shows the production of various T antigens in STAT1
(/) MEFs expressing either SV40-ER or the N136 equivalents.
As described earlier, whole cell extract and total RNA from these
pools were evaluated. Results from both western blot and RT-PCR
showed that none of the T antigen expressing pools examined
(SV40-ER or N136 equivalents) exhibited increased levels of ISGs
(Fig. 7C and D).
Next, we sought to determine if STAT1 was required by
T antigen to induce the antiviral state. We quantiﬁed VSV production
from STAT1(/) MEFs by plaque assay. We did not obtain a robust
difference between the level of VSV produced from STAT1(/)
MEFs and SV40-ER expressing STAT1(/) MEFs (Fig. 7E). Further-
more, Fig. 7E reveals that the SV40-ER STAT1(/) MEFs produced
nearly the same amount of VSV(pfu/mL) as wild-type MEFs from
12–48 h (Fig. 6A). Together, our data suggests that STAT1 transcrip-
tion factor is necessary for the upregulation of ISGs by T antigen, and
that ISG production is necessary to induce the antiviral state.
Discussion
Expression of the ERs from SV40, BKV, and JCV in MEFs results
in the production of various T antigen proteins via alternative
splicing of the early pre-mRNA transcript. In our system, MEF
pools expressing the ER of SV40 or JCV produced LT, were able to
upregulate ISGs, and generate an antiviral state as assessed by VSV
and EMCV infection. Interestingly, we could only detect what
appears to be truncated T antigen or sT, but not LT protein from the
MEFs expressing BKV-ER. We have shown that this was not a
failure of the assay to detect LT from BKV-ER MEFs because we can
detect large amounts of BKV LT in the BKV LT cDNA expressing
MEFs (Fig. 3A). We conclude that alternative splicing favors the
production of alternative mRNAs when the entire early region is
expressed. The results suggest that T antigen's ability to activate
the antiviral state, at least with BKV, must be limited to activity
found within its small or truncated T antigens.
Because the sT and truncated T antigens share characteristics
(e.g. J-Domain and Rb binding motif) with the N136 equivalent
mutants described above, we hypothesized that N136, N137, and
N138 would be able to induce the antiviral state as seen in MEF
Fig. 5. T antigen mutants C257 and E107/E108K are defective for the upregulation of ISGs. (A) Western blot of total and activated STAT1 levels. Wild-type MEF (lane 1), MEFs
expressing SV40-ER (lane 2), and MEFs expressing N136 (lane 3) are included for comparison to E107/8K mutant STAT1 production/ activation in lanes 4–6. Lane 4 is a MEF
pool expressing N136 E107/8K, and lanes 5–6 are full length SV40 T antigen E107/8K mutant expressing clones (C1 and C2). (B) Steady state levels of E107/8K mutant
T antigens (lanes 1–3) and an SV40-ER expressing MEF pool T antigen were determined by western blot. (C) Diagram of the SV40-C257 mutant and its features are shown.
(D) Western blot showing the production of STAT1 and STAT2 in whole cell extract from wild-type MEFs (lane 1) or two MEF pools—P1 or P2–expressing C257 lanes 3–4).
SV40-ER expressing MEFs are included for comparison (lane 2). E) RT-PCRs for various ISGs using cDNA made from 2 μg of total RNA from wild-type MEFs (lane 1), or MEF
pools expressing C257 (lane 3–4).
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pools expressing the early region. Further analysis showed the
antiviral state was clearly established in the MEF pools expressing
any of the N136 equivalents. We also examined the role of sT in
ISG induction. Expression of constructs unable to produce sT still
retained the ability to upregulate ISGs. However, we cannot rule
out the possibility that sT from SV40, BKV, or JCV expressed
independently can activate ISGs.
The activity of T antigen necessary to activate the ISGs requires
an intact LXCXE (pRB binding) motif. Mutation of the LXCXE motif,
either in full length LT or the N136 truncation, resulted in a failure
to upregulate the activation state of STAT1 S727. Therefore, it is
possible that the binding of pRB family members is required to
induce the upregulation of ISGs. However, it is also possible that
the LXCXE motif is capable of binding other partners besides pRB
family members, and those are necessary for STAT1 activation.
Indeed, previous studies have shown that the LXCXE motif is
capable of binding insulin receptor substrate 1 (IRS1) which
resulted in the activation of protein kinase B (AKT) (Yu and
Alwine, 2008). We examined the effect of AKT activation on ISG
upregulation, but concluded that AKT activation by T antigen is not
related to the induction of ISGs (data not shown). In an earlier
study we reported that the association of SV40 LT with p53 is
necessary for ISG induction (Rathi et al., 2010). This study utilized
MEF clones expressing N136 rather than early passage cell pools
used in the current study. The N136 clones underwent crisis prior
to their establishment as stable cell lines. We hypothesize that
mutations arising during clonal selection explain the difference in
results.
The evidence presented in this study shows that the upregula-
tion of ISGs by T antigen is dependent upon the presence of STAT1,
and that LT failed to induce the upregualtion of ISGs as well as an
antiviral state in STAT1(/) MEFs. This indicates that STAT1 is
critical. However, the mechanism by which T antigen manages to
induce the activation of STAT1 via the LXCXE motif remains
unresolved. Alternatively, the level of LT expression in SVT-ER
STAT1(/) MEFs is lower relative to normal SVT-ER MEFs
(Fig. 7B), and that this may explain the lack of ISG induction in
the SVT-ER STAT1(/) MEFs. However, we ﬁnd this highly
unlikely because we have observed full ISG induction with very
low levels of T antigen. These cases arise because some MEF pools
express low T antigen levels or some T antigen mutants lower the
steady state levels of T antigen.
We have previously shown that LT also induces ISGs and an
antiviral state in human ﬁbroblasts (Forero et al., 2014); however,
the mechanism appears to differ from what occurs in MEFs. In
human cells ISG induction is mediated by the DNA damage
response and the production of secreted interferon signal (Forero
et al., 2014). In contrast, in MEFs ISGs are induced irrespective of
interferon production (Rathi et al., 2010), and therefore it seems
unlikely that the antiviral state in these cells would be established
through a similar mechanism. Further more sensitive assays may
be necessary to conﬁrm that MEFs upregulate ISGs via an inter-
feron independent mechanism, but in either case our investigation
extends upon the previously known phenomena that expression of
the LT from SV40 in mouse or human ﬁbroblasts can activate ISGs
(Rathi et al., 2010; Forero et al., 2014).
Fig. 6. T antigen inhibits growth of VSV and ECMV. (A) The titer of VSV (pfu/mL) on wild-type MEFs over 48 h. Samples were collected at various time points and the virus
titer was determined by plaque assay on BHK21 cells. (B) VSV growth on MEFs expressing the ER of SV40, BKV, or JCV. The y-axis values shown are a proportion of VSV
produced from ER expressing MEFs to VSV produced from wild-type MEFs at the corresponding time, which are shown in panel A. The dashed line indicates VSV growth on
wild-type MEFs. (C) VSV growth on MEFs expressing N136 equivalents (N136, N138, or N137). Again, the dashed line indicates of VSV growth on wild-type MEFs. (D) Titer of
EMCV produced (pfu/mL) from SV40-ER expressing MEFs (SVT), and N136 expressing MEFs (N136). ECMV titer in wild-type MEFs is represented as the dotted line (wt). In all
panels (A–D), error bars represent standard error of the mean.
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In this study we have described that the stable expression of
different polyomavirus T antigens in MEFs triggers the upregula-
tion of ISGs and subsequently establishes an antiviral state. This is
the ﬁrst report, to our knowledge, that describes these phenotypes
for BKV and JCV T antigens in mouse cells. Our results suggest that
T antigen activity via the LXCXE motif leads to the activation of
STAT1, and may be critical to the increase of ISG transcription.
Furthermore, our data indicate that STAT1 and ISGs play a crucial
role in mediating the antiviral response by T antigen.
Materials and methods
Plasmids and constructs
Cloning of pBABEpuro-SV40-ER, BKV-ER, and JCV-ER involved
the conversion of pBABEpuro into a Gateways destination vector
using the Gateways Vector Conversion System (Invitrogen, catalog
#11838-029) by ligating the reading frame cassette C.1 into the
SnaBI site. attB-PCR products of the early regions of SV40, BKV and
JCV were generated according to the “attB Adapter PCR” procedure
in the Gateways Technology with Clonase II kit (Invitrogen,
catalog #12535-029) using template DNA pSVB3 (Peden et al.,
1980), pBKV (JF894228) and pJCmad1 (gift from Keith Peden,
NC_001699) for SV40, BKV and JCV, respectively. Template-
speciﬁc primers were designed to contain a Kozak consensus
sequence (50-ACC-30) immediately upstream of the ATG start site.
attB-PCR products were cloned into pDONR221 using the BP
recombination reaction and the resulting plasmid was recombined
by an LR reaction with pBABEpuroDEST to create the early region
expression clone. All procedures were followed as recommended
by the manufacturer.
Cloning of pLenti6.3 (Invitrogen #K5315-20) constructs was per-
formed in accordance with the manufacturer's instructions. An addi-
tional Kozak sequence (ACC) was introduced directly upstream of the
start codon to enhance translation of the construct. N136 equivalent
and C257 mutants were previously described (Robles et al., 2013)
Additional full length SV40 LT E107K/E108K mutants were described
(Rathi et al., 2010). The full length LT cDNA constructs were prepared
by ampliﬁcation via RT-PCR. Restriction sites EcoRI and NotI were
introduced with primers during ampliﬁcation. Following restriction
digestion and gel puriﬁcation the DNA fragments were ligated into the
pEF1/V5-His plasmid (Invitrogen #V920-20) at the corresponding
sites. Constructs were veriﬁed by sequencing.
Isolation of primary mouse embryonic ﬁbroblasts, conditions of cell
culture, and establishment of pools
Mouse embryonic ﬁbroblasts (MEFs) and STAT1(/) MEFs
were harvested from 13.5 day old FVB embryos using the method
previously described (Markovics et al., 2005). MEFs were grown in
DMEM (Corning #10-013-CV) supplemented with 10% fetal bovine
serum (HYCLONE#: SH30070.03) and 1% penicillin/streptomycin
(Invitrogen #15140163). MEFs were grown at 37 1C with 5% CO2.
Fig. 7. STAT1 is necessary for induction of ISGs and generation of the antiviral state. (A) Western blots of T antigen production fromwild-type MEFs and SV40-ER expressing
MEF pools in both normal MEF and in the STAT1(/) MEF backgrounds. (B) Western blot of N136 equivalent mutants expressed in STAT1(/) MEFs. (C and D) RT-PCR
analysis of various ISGs using cDNA made from 2 μg of total RNA fromwild-type MEFs and MEF pools expressing T antigen in both the normal and STAT1(/) backgrounds.
Lane 2 of both C and D are SV40-ER expressing MEFs and serve as a positive control for ISG upregualtion. (E) VSV growth on STAT1(/) MEFs. The y-axis values shown are a
proportion of VSV produced from STAT1 (/) MEFs or STAT1 (/) MEFs expressing SVT-ER to VSV produced from wild-type MEFs at the corresponding time, which are
shown in panel of Fig. 6A. The dashed line indicates VSV growth on wild-type MEFs. In E, error bars represent standard error of the mean. The data shown is representative of
all pools tested.
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Plasmids encoding different T antigen mutants were trans-
fected with lipofectamine 2000 reagent (Invitrogen 11668-027)
into the producer cell line, 293FT (Life technologies #R700-07) for
production of lentivirus in accordance with manufacturer's
instructions. Pools of MEF cells expressing different constructs
were then generated via lentiviral transduction (Invitrogen
ViraPower #K4975-00) with 12 μg/ml polybrene reagent (Sigma
#H9268). Lentivirus transduction conveyed the pL6.3 lenti/V5
TOPO plasmid (Invitrogen #K5315-20) expressing a genomic
version of different mutant large T antigens (SV40-N136, BKVT-
N138, JCVT-N137, SV40 C257-708, or N136 E107/E108K). Following
lentiviral infection of MEFs, cells were grown to conﬂuency and
selected for 7–10 days in 2 μg/mL blasticidin (Life Technologies
#R210-01). Surviving colonies were pooled and passaged until
approximately passage four, except for the MEF pool expressing
N136 E107/E108K. They could not be passaged beyond selection, as
those cells did not transform/immortalize with expression of the
mutated N136 construct. Instead they were collected 2 days post-
conﬂuency, passage zero. All other selected MEF pools were
collected for further analysis at passage Zfour.
MEF pools expressing viral ER were generated by a similar
transduction, using retroviral vectors. The ER were cloned into the
pBABE puro plasmid (kindly provided by Ole Gjoerup), utilizing a
murine maloney leukemia retrovirus promoter, and transfected
into phoenix eco-cells (ATCC #CRL-3214). Retrovirus made from
producer cell lines were used to infect MEFs. Subsequent selection
was carried out in a similar fashion using 2 μg/mL puromycin for
7–10 days. Surviving clones were pooled and passaged to approxi-
mately passage four, and cellular pellets were collected.
MEFs expressing Large T antigen cDNAs were generated via
transfection with pEF1/V5-HisA plasmids (Invitrogen) expressing
the cDNA of the various LTs. Plasmids were introduced via FUgene
6 (Promega #E2691) transfection in accordance with manufac-
turer's instructions, and MEF pools were obtained after selection
with 200 μg/mL Neomycin,G418, (Cellgro #: 30-234-CR) for 7–10
days. MEF cell lines expressing full length LT E107/108K mutation
were previously described (Rathi et al., 2010), and expressed the
mutated LT via pRSVneo plasmid (Srinivasan et al., 1997). The
clones were isolated, grown, collected, and samples of whole cell
extract were prepared as described below.
Virus growth and plaque assays
Wild-type MEFs or MEF pools stably expressing T antigen were
plated in 6 cm dishes and infected with VSV the following day at a
multiplicity of infection (MOI) of 0.1. At the time of infection, cells
were counted to establish the correct MOI. Infection lasted for 1 h
in a 37 1C, 5% CO2 incubator, rocking the plates every 15 min.
Afterward, the virus was removed and 2.5 mL of growth medium
was supplied. Plates were collected at different time points and
frozen at 80 1C. Plates were thawed, and the supernatant was
collected by centrifugation at 3000 rpm for 15 min. Infections for
each condition were performed across at least two different MEF
lineages.
Infections with EMCV were performed with wild type MEFs or
MEF pools expressing T antigen. The cells were plated and allowed
to grow overnight. The following day cells were counted, seeded in
plates (2e6 cells/plate) and infected with EMCV at a MOI of
0.005. Infection lasted for one hour at 37 1C in a 5% CO2 incubator,
rocking the plates every 15 min. Afterward, the viruses were
removed; plates were washed three times in 1X PBS, and 2.5 mL
of growth media was supplied. Plates were collected at 0, 3, and
6 h post-infection, and frozen at 80 1C. Plates were freeze/
thawed 2 times, and viral supernatant was collected via centrifu-
gation at 3000 rpm for 15 min.
Infectious virus production was quantiﬁed by plaque assay.
Supernatant produced from cells infected with VSV was serially
diluted in DMEM and used as inoculum for infection of BKH21
cells (ATCC: #CCL-10). BHK21 cells were infected for 1 h in a 37 1C,
5% CO2 incubator, rocking every 15 min. Media containing virus
was removed and cells were overlaid with 1.5% agarose (LONZA
#50100) with 2X MEM (LifeTechonologies #61100) and 10% FBS.
Twenty-four to thirty-six hours post-infection, viral plaques were
visualized with the addition of 1% neutral red solution (Sigma).
The same procedure was used to quantify EMCV production with
two exceptions: VERO cells (ATCC # CCL-81) were used for viral
infection, and plates were stained at 36–48 h post-infection to
visualize plaques.
Immunoblot analysis
Western blots were conducted as previously described (Markovics
et al., 2005) with the following antibodies: Total STAT1 (Cell Signal
#9172), Phospho-STAT1 Ser727 (Cell Signal #9177), and Total STAT2
(Cell Signal #4597) and were prepared in accordance with the
manufacturer's instructions. SV40 T Antigen mouse monoclonal anti-
bodies have been described previously: PAb416, PAb419 (Harlow et al.,
1981), and PAb901 (Fu et al., 1996). Additional mouse monoclonal
antibodies against JCV T antigens (PAb962 and AB2003) were pre-
viously described (Bollag et al., 2000; Munoz-Marmol et al., 2004).
GAPDH mouse monoclonal was used as the loading control (US
Biologicals #G8140-11). Peroxidase-conjugated goat anti-mouse
(A2554), and goat anti-rabbit (A0545) from Sigma-Aldrich were used
as secondary antibodies. The Luminata Western HRP substrate (Milli-
pore #WBLUF0100) was used in accordance with manufacturer's
instructions. A mixture of monoclonal antibodies 416/419/962/2003
(1:1000/1:500/1:1000/1:1000) were used for the detection of T
antigen signal in Figs. 2C, 3A, 4B, and 7B. Additionally, SV40-C257
detection used monoclonal Ab901 (1:500) in Fig. 5D, and in Fig. 5B a
mixture of 416/419 (1:500/1:250) was used.
Whole cell extract, RNA extraction, and reverse transcription PCR
MEF cells were grown for two days post-conﬂuency, trypsi-
nized, and pelleted by centrifugation. Cell pellets were washed in
1X PBS and frozen at 80 1C. Total RNA was extracted with the
Qiagen RNeasy kit (#74104) in accordance with manufacturer's
instructions. Samples were quantiﬁed using a NanoDrop2000.
Proteins extracts from whole cell extract were prepared by lysis
in [HEPES pH 7.9 50 mM, KCl 0.4 M, EDTA 0.5 mM, NP40 0.1%,
Glycerol 10%], and lysates were centrifuged for 15 min at 4 1C to
remove insoluble material. Quantiﬁcation of extracts was per-
formed by Bradford protein assay (BioRad #500-0006) in accor-
dance with manufacturer's instructions on a BioRad iMArk
microplate reader.
Reverse transcription PCR for the production of cDNA from
total RNA (2 μg) was reverse-transcribed with the SuperScript III
First-Strand Synthesis System for RT-PCR (Invitrogen #18080-051)
in accordance with manufacturer's instructions. PCR analysis with
gene speciﬁc primers (Rathi et al., 2010) was performed using
equal amounts of cDNA and GOTaq polymerase (Promega #M712).
PCR conditions were described previously (Rathi et al., 2010). Rpl5
served as a loading control. The reactions were resolved through
1% agarose gels and visualized with ethidium bromide (Sigma-
Aldrich #E1510).
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